Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$11.15 -0.45 (-3.88%)
As of: Nov 12, 2026 · 2:09 PM EST

Enanta Pharmaceuticals (ENTA) Sales of Property, Plant and Equipment (2012)

Updated

Enanta Pharmaceuticals (ENTA) reported Sales of Property, Plant and Equipment of $9,000 for FY2015 (year ended Sep 30, 2015), up 200.0% from $3,000 in FY2014.

Analysis

Enanta Pharmaceuticals (ENTA) Sales of Property, Plant and Equipment (2012) Analysis & Trends

Dating back to FY2011, Enanta Pharmaceuticals' Sales of Property, Plant and Equipment record includes 4 fiscal years.

  • Sales of Property, Plant and Equipment has a four-year compound annual growth rate of 0.0% (FY2011 to FY2015).
  • The FY2015 figure ranks as the highest annual Sales of Property, Plant and Equipment since FY2012.
  • According to Business Quant data, Sales of Property, Plant and Equipment came in at $3,000 in FY2014, $66,000 in FY2012 (+633.3%) and $9,000 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -4.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Enanta Pharmaceuticals 326.73 Mn -401.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2012 8,000.00
API Access

Enanta Pharmaceuticals Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=ENTA&period=max&api_key=YOUR_API_KEY